Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief Report

INTRODUCTION: Previously, we developed a database of 693 patients with NSCLC and uncommon EGFR mutations treated with afatinib. Here, we provide an update of >1000 patients, with more data on specific mutations. METHODS: Patients were identified from a prospective database developed by Boehringer...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, James Chih-Hsin, Schuler, Martin, Popat, Sanjay, Miura, Satoru, Park, Keunchil, Passaro, Antonio, De Marinis, Filippo, Solca, Flavio, Märten, Angela, Kim, Edward S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104339/
https://www.ncbi.nlm.nih.gov/pubmed/35574304
http://dx.doi.org/10.3389/fonc.2022.834704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104339/
https://www.ncbi.nlm.nih.gov/pubmed/35574304
http://dx.doi.org/10.3389/fonc.2022.834704

Ejemplares similares